Greenbrook TMS Announces Dates for Its First Quarter 2021 Financial Results and Provides Corporate Update
20 April 2021 - 11:01PM
Business Wire
Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH)
(“Greenbrook” or the “Company”), will release its
first quarter 2021 operational and financial results after market
hours on May 12, 2021.
FIRST QUARTER 2021 CONFERENCE CALL DETAILS
Bill Leonard, President and Chief Executive Officer, and Erns
Loubser, Chief Financial Officer, will host a conference call at
10:00 a.m. (Eastern Time) on May 13, 2021 to discuss the financial
results for the quarter.
Dial in Numbers:
Toll Free North America: (866) 521-4909 Toronto: (647)
427-2311
Webcast:
For more information or to listen to the call via webcast,
please visit: https://www.greenbrooktms.com/investors/events
For those that plan on accessing the conference call or webcast,
please allow ample time prior to the call time.
Conference Call Replay:
Toll Free (North America): (800) 585-8367 Toronto: (416)
621-4642 Conference ID: 6679987
The conference call replay will be available from 1:00 p.m. ET
on May 13, 2021, until 11:59 p.m. ET on June 12, 2021.
CORPORATE UPDATE
Greenbrook also announced today that Erns Loubser will be
returning to the role of Chief Financial Officer and Treasurer
following his previously announced medical leave of absence. In
connection with Mr. Loubser’s return, Ed Cordell will be stepping
down from his role as Interim Chief Financial Officer but will
remain with the Company until his responsibilities have been fully
transitioned to Mr. Loubser.
About Greenbrook TMS Inc.
Operating through 128 Company-operated treatment centers,
Greenbrook is a leading provider of Transcranial Magnetic
Stimulation (“TMS”) therapy, an FDA-cleared, non-invasive
therapy for the treatment of Major Depressive Disorder and other
mental health disorders, in the United States. TMS therapy provides
local electromagnetic stimulation to specific brain regions known
to be directly associated with mood regulation. Greenbrook has
provided more than 560,000 TMS treatments to over 15,000 patients
struggling with depression.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210420005814/en/
Glen Akselrod Investor Relations Greenbrook TMS Inc.
Contact Information: investorrelations@greenbrooktms.com
1-855-797-4867
Greenbrook TMS (TSX:GTMS)
Historical Stock Chart
Von Dez 2024 bis Jan 2025
Greenbrook TMS (TSX:GTMS)
Historical Stock Chart
Von Jan 2024 bis Jan 2025